Literature DB >> 23569729

Malaria vaccines: looking back and lessons learnt.

Veronique Lorenz1, Panagiotis Karanis.   

Abstract

The current status of malaria vaccine approaches has the background of a long and arduous path of malaria disease control and vaccine development. Here, we critically review with regard to unilateral interventional approaches and highlight the impact of socioeconomic elements of malaria endemicity. The necessity of re-energizing basic research of malaria life-cycle and Plasmodium developmental biology to provide the basis for promising and cost-effective vaccine approaches and to reach eradication goals is more urgent than previously believed. We closely analyse the flaws of various vaccine approaches, outline future directions and challenges that still face us and conclude that the focus of the field must be shifted to the basic research efforts including findings on the skin stage of infection. We also reflect on economic factors of vaccine development and the impact of public perception when it comes to vaccine uptake.

Entities:  

Keywords:  Current state; Malaria; Vaccine

Mesh:

Substances:

Year:  2011        PMID: 23569729      PMCID: PMC3609149          DOI: 10.1016/S2221-1691(11)60072-5

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  29 in total

1.  Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Authors:  Faith H A Osier; Gregory Fegan; Spencer D Polley; Linda Murungi; Federica Verra; Kevin K A Tetteh; Brett Lowe; Tabitha Mwangi; Peter C Bull; Alan W Thomas; David R Cavanagh; Jana S McBride; David E Lanar; Margaret J Mackinnon; David J Conway; Kevin Marsh
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

2.  Measles in Europe: an epidemiological assessment.

Authors:  Mark Muscat; Henrik Bang; Jan Wohlfahrt; Steffen Glismann; Kåre Mølbak
Journal:  Lancet       Date:  2009-01-07       Impact factor: 79.321

Review 3.  Immunosenescence and vaccine failure in the elderly.

Authors:  Beatrix Grubeck-Loebenstein; Silvia Della Bella; Anna Maria Iorio; Jean-Pierre Michel; Graham Pawelec; Rafael Solana
Journal:  Aging Clin Exp Res       Date:  2009-06       Impact factor: 3.636

Review 4.  DNA vaccines for parasitic infections.

Authors:  B H Kalinna
Journal:  Immunol Cell Biol       Date:  1997-08       Impact factor: 5.126

5.  Malaria vaccine development based on merozoite surface proteins of Plasmodium falciparum.

Authors:  Virander S Chauhan; Syed Shams Yazdani; Deepak Gaur
Journal:  Hum Vaccin       Date:  2010-09-13

Review 6.  Vaccines against malaria - an update.

Authors:  Kai Matuschewski; Ann-Kristin Mueller
Journal:  FEBS J       Date:  2007-09       Impact factor: 5.542

Review 7.  Do we still need a malaria vaccine?

Authors:  B Greenwood; G Targett
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

Review 8.  Prime-boost strategies for malaria vaccine development.

Authors:  Susanna J Dunachie; Adrian V S Hill
Journal:  J Exp Biol       Date:  2003-11       Impact factor: 3.312

9.  CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes.

Authors:  Sumana Chakravarty; Ian A Cockburn; Salih Kuk; Michael G Overstreet; John B Sacci; Fidel Zavala
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

Review 10.  Malaria pathogenesis.

Authors:  L H Miller; M F Good; G Milon
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

View more
  1 in total

Review 1.  Malaria vaccine development and how external forces shape it: an overview.

Authors:  Veronique Lorenz; Gabriele Karanis; Panagiotis Karanis
Journal:  Int J Environ Res Public Health       Date:  2014-06-30       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.